biotech · Non small cell lung cancer · oligometastatic hormone sensitive prostate cancer · CERO
CERo Therapeutics
CERO THERAPEUTICS HOLDINGS, INC.
CERo Therapeutics events on NovaPharmaNews — congress presentations and investor conference coverage.
201 Haskins Way, 230, South San Francisco, California 94080, US HQ
17 Employees
Public company Type
CERO · NYSE Ticker
Company details
- Status
- Public
- HQ
- 201 Haskins Way, 230, South San Francisco, California 94080, US
- Employees
- 17
- Programs
- 47
- Drugs
- 84
- Patents
- 14
Events
CERo Therapeutics events on NovaPharmaNews — congress presentations and investor conference coverage.
CERo Therapeutics events on NovaPharmaNews — congress presentations and investor conference coverage.